Europeanhhm

QuantalX and Sheba Longevity Center Join Forces to Promote Brain Health Across All Ages

Wednesday, May 22, 2024

QuantalX Neuroscience, a leading medical device company specializing in Brain Health diagnosis, has announced a significant partnership with The Sheba Longevity Center, part of the prestigious Sheba Medical Center, Israel.

This collaboration marks a pivotal moment in advancing brain health across the lifespan and underscores QuantalX's commitment to innovative healthcare solutions.

QuantalX recognizes the global trend of population aging, with projections indicating a substantial increase in the elderly population by 2050.

This partnership with Sheba Longevity Center is a strategic step towards addressing the evolving healthcare needs of aging populations worldwide.

"Partnering with Sheba Longevity Center allows us to combine our cutting-edge Delphi-MD technology with world-class expertise to revolutionize brain healthcare," said Iftach Dolev PhD, CEO and Co-Founder of QuantalX Neuroscience.

The collaboration aims to leverage advanced predictive analytics through QuantalX's cutting-edge technology to promote brain health and well-being throughout life.

This partnership focuses on proactive healthcare management, early detection of brain abnormalities, and personalized intervention strategies, contributing significantly to enhancing the quality of life for aging individuals.

Led by distinguished experts at the Sheba Longevity Center, this collaboration will pioneer new approaches in health diagnostics and intervention strategies. By combining expertise and resources, QuantalX and Sheba Longevity Center are poised to redefine brain healthcare and empower individuals to lead healthier lives as they age.

Chief Scientific Officer of Sheba Longevity Center, further elucidated the vision behind this collaboration "In the next two years, we will dedicate our efforts in establishing a risk prediction model for early detection of mild cognitive impairment among healthy individuals based on the DELPHI test results."

"The collaboration between The Sheba Longevity Center and QuantalX Neuroscience marks a significant milestone in advancing brain health diagnostics worldwide. By combining our expertise and resources with QuantalX's state-of-the-art technologies, we are leading a transformative shift in healthcare.

This partnership reinforces our dedication to innovative solutions and underscores our commitment to improving health outcomes on a global scale."

 

 

 

 

Source: prnewswire.com

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital Congress